z-logo
open-access-imgOpen Access
Synthesis and activity of N-(o-tolyl)caffeamide and N-(o-tolyl)-p-coumaramide against P388 leukemia murine cells
Author(s) -
Firdaus Firdaus,
Seniwati,
N. Alamsyah,
Swandari Paramita
Publication year - 2019
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/1341/3/032005
Subject(s) - chemistry , amide , proton nmr , carbon 13 nmr , stereochemistry , absorption (acoustics) , biological activity , medicinal chemistry , nuclear chemistry , organic chemistry , materials science , biochemistry , in vitro , composite material
Ester derivatives of p -hydroxycinnamic compounds have high anticancer activity. However, the ester compounds usually easier to be decomposed than their amide derivates, so the ester compounds have a low potential to be applied as anticancer. In this research, the amide derivatives of caffeic and p -coumaric acids have been synthesized using o -tolylamine to give trans - N -( o -tolyl)caffeamide ( 5a ) and trans - N -( o -tolyl)- p -coumaramide ( 5b ), respectively. The products were characterized by FT-IR, 13 C-NMR, and 1 H-NMR methods. In the FT-IR spectrum, compound 5a showed absorption bands of N-H bond at 3236.55 cm −1 and 1533.41 cm −1 as stretching and bending vibrations, respectively; and compound 5b had absorption bands at 3267.41 cm −1 and 1527.82 cm −1 . In the 13 C-NMR spectrum, compound 5a gave 15 of peaks that representing 16 of carbons, and compound 5b gave 14 of peaks that were also representing 16 of carbons. In the 1 H-NMR spectrum, the peak of N-H of compound 5a and compound 5b appeared at 8.57 ppm and 8.87 ppm, respectively. Activity assay results of both compounds against P388 leukemia murine cells indicated that both compounds have a high potential as anticancer, especially compound 5a . The compound 5a was more active than the analogous compounds which the previous synthezised.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here